百本醫護(02293.HK)年度淨利3070萬港元 同比減少約21.1%
格隆匯 9 月 18日丨百本醫護(02293.HK)公告,截至2020年6月30日止年度的收益約7230萬港元,同比減少約7.9%。公司權益持有人應占溢利約3070萬港元,同比減少約21.1%。每股基本及攤薄盈利7.67港 仙。截至2020年6月30日止年度建議末期股息每股普通股2.5港仙(2019年:每股普通股5.0港仙)。
集團於年度的收益包括(i)提供醫護人手解決方案服務所得收益;(ii)提供外展個案評估相關服務所得收益;及(iii)於香港經營美容診所所得收益。
鍳於COVID-19疫情的影響,市場對於醫療服務的需求因部分醫療設施暫時關閉而減少。然而,由於醫療及健康評估服務的需求增加,公司來自提供外展個案評估相關服務所得收益輕微增加了20萬港元。
提供醫護人手解決方案服務所得收益佔總費用百分比乃經參考集團對客户的收費率與向集團配置的不同職級醫護人員作出的付費率間的加成率,以及各個別職級醫護人員所提供服務的時數釐定。提供醫護人手解決方案服務所得收益佔總費用百分比由截至2019年6月30日止年度的約27.2%輕微增至年度的約27.4%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.